Insights on the Mucosal Atomization Devices Global Market to 2027 – Featuring Kurve Technology, Cook Medical, Medica Holdings and Integra LifeSciences Among Others – ResearchAndMarkets.com

Insights on the Mucosal Atomization Devices Global Market to 2027 – Featuring Kurve Technology, Cook Medical, Medica Holdings and Integra LifeSciences Among Others – ResearchAndMarkets.com




Insights on the Mucosal Atomization Devices Global Market to 2027 – Featuring Kurve Technology, Cook Medical, Medica Holdings and Integra LifeSciences Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Mucosal Atomization Devices Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022-2027)” report has been added to ResearchAndMarkets.com’s offering.

The mucosal atomization devices market is projected to record a CAGR of nearly 7.25% over the forecast period.

Companies Mentioned

  • Teleflex Incorporated
  • DeVilbiss Healthcare LLC
  • Becton, Dickinson and Company
  • Kurve Technology Inc.
  • Cook Medical
  • Medica Holdings
  • Integra LifeSciences
  • BVM Meditech Private Limited

Key Market Trends

Gas-propelled Expected to be a Fast-growing Segment over the Forecast Period

Gas-powered or propelled drug delivery systems were among the first developed systems. It uses gas or an air cartridge attached to the gun either directly or indirectly through a tubing system to deliver power to the injector piston. When the trigger is activated, it releases the piston and creates a jet stream of medicant through the nasal, buccal, and trachea. Gas-propelled delivery offers the benefit of being extremely flexible.

Owing to the variety of liquefied gases available, it’s possible to provide a complete spectrum of pressure ranges within a single container format. This allows a single device system to manage a variety of delivery options, including different viscosities (up to 300 cP and much higher with a new variation on the technology), injection volumes, and primary containers.

Several key players in the market are focusing on developing novel gas-propelled devices for the easy and safe administration of drugs. Bespak is a company with a broad portfolio of gas-propelled drug delivery devices. The company’s Unidose Xtra nasal spray device is one such spray device that can be customized for the drug delivery of various requirements of patients. Unidose (UDS) systems are ready-to-use, one-step nasal drug delivery devices that convert liquid formulations to release the medicament as a spray using gas- or air-powered technology.

Impel NeuroPharma is developing Precision Olfactory Delivery (POD) technology, a proprietary drug delivery technology system, that uses gas propelling technology to target the vascular-rich upper nasal space. In January 2021, the US Food and Drug Administration accepted the company’s 5O5 (b)(2) New Drug Application (NDA) for INP104 for the acute treatment of migraine headaches with or without aura in adults. INP104 is dihydroergotamine mesylate (DHE) delivered directly into the vascular-rich upper nasal space using Impel’s proprietary Precision Olfactory Delivery (POD) technology.

Thus, owing to the aforementioned factors, the application of gas-propelled mucosal atomization devices is expected to grow significantly during the forecast period.

North America Dominates the Market and is Expected to Continue Dominance over the Forecast Period

North America is expected to dominate the global market throughout the forecast period. The market growth is due to factors, such as the presence of key players, the high prevalence of allergic rhinitis and sinus in the region, and established healthcare infrastructure. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth. In this region, the US holds the maximum share due to supportive healthcare policies, a high number of patients, and a developed healthcare market.

Key Topics Covered:

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Adoption of Mucosal Atomization Devices

4.2.2 Increasing Prevalence of Allergic Rhinitis and Sinus

4.3 Market Restraints

4.3.1 Side Effects Due to Overdose

4.4 Porter’s Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value- USD Million)

5.1 Product Type

5.2 End User

5.3 Geography

6 COMPETITIVE LANDSCAPE

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/ktku5g

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900